Perfil
Kelly O’Brien Wilson currently works at Forte Animal Health, Inc., as Director from 2020 and Biostax Corp., as Chief Operating Officer from 2022.
Ms. Wilson also formerly worked at Biostax Corp., as CTO & Director-Human Resources from 2015 to 2020, Biostax Corp., as Chief Executive & Operating Officer in 2023, and Cytocom, Inc., as Chief Technology & Information Officer from 2016 to 2020.
Ms. Wilson received her undergraduate degree and graduate degree from the University of Central Florida.
Cargos activos de Kelly Wilson
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOSTAXPAR | Director de Operaciones | 01/08/2022 |
Forte Animal Health, Inc. | Director/Miembro de la Junta | 01/12/2020 |
Antiguos cargos conocidos de Kelly Wilson.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOSTAXPAR | Director Ejecutivo | 25/07/2023 |
| BIOSTAXPAR | Director Técnico/Científico/I+D | 01/04/2020 |
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Director Técnico/Científico/I+D | 01/04/2020 |
Formación de Kelly Wilson.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Central Florida
University of Central Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biostax Corp.
Biostax Corp. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical & biotechnology products | Health Technology |
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Health Technology |
Forte Animal Health, Inc. | Process Industries |
- Bolsa de valores
- Insiders
- Kelly Wilson
















